SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Revenue

SMS Pharmaceuticals had revenue of 3.17B INR in the quarter ending September 30, 2026, with 30.94% growth. This brings the company's total for the last twelve months to 9.74B, up 13.28% year-over-year. In the fiscal year ending March 31, 2026, SMS Pharmaceuticals had annual revenue of 8.89B with 13.53% growth. That makes SMS Pharmaceuticals the 22,410th largest company in the world by revenue and 1,346th in India.

• Revenue (ttm): 9.74B
• Revenue Growth: +13.28%
• P/S Ratio: 4.93
• Revenue / Employee: 6.03M
• Employees: 1,617
• Market Cap: 48.98B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Exports 5.96B 67.2%
• India 2.91B 32.8%

Fiscal year ended Mar 31, 2026 See the full SMS Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.89B	1.06B	13.53%
Mar 31, 2025	7.83B	734.85M	10.36%
Mar 31, 2024	7.09B	1.87B	35.86%
Mar 31, 2023	5.22B	21.77M	0.42%
Mar 31, 2022	5.20B	-433.03M	-7.69%

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error